Results 201 to 210 of about 12,272 (217)

Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia

Cancer Cell, 2016
Shanye Yin, Thomas J Kipps, David S DeLuca   +2 more
exaly  

A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion

Cancer Cell, 2019
Ignaty Leshchiner, Shanye Yin, Thomas J Kipps   +2 more
exaly  

SF3B1 AND MDS-RS: THE BIOLOGICAL PERSPECTIVE

Leukemia Research, 2023
openaire   +1 more source

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Blood, 2011
Mario Cazzola, Luca Malcovati, Anna Gallì   +2 more
exaly  

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms

Blood, 2013
Mario Cazzola, Luca Malcovati, Marianna Rossi   +2 more
exaly  

Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing

Breast Cancer, 2020
Jing Liu, Caixia Cheng
exaly  

Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

Leukemia, 2013
T Alpermann, V Grossmann, S Schnittger
exaly  

Uveal Melanomas with SF3B1 MutationsA Distinct Subclass Associated with Late-Onset Metastases

Ophthalmology, 2016
Dion Paridaens, Jolanda Vaarwater, Annelies de Klein   +2 more
exaly  

SF3B1 SUPPRESSION AS A THERAPY FOR TUMORS HARBORING SF3B1 COPY LOSS

2017
BEROUKHIM RAMEEN, PAOLELLA BRENTON, GIBSON WILLIAM J   +2 more
openaire   +1 more source

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

Blood, 2011
Francesco Bertoni, Valter Gattei, Ilaria Del Giudice   +2 more
exaly